Jefferies Financial Group’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.04M | Sell |
43,592
-130,700
| -75% | -$3.12M | 0.01% | 518 |
|
|
2025
Q1 | $4.33M | Buy |
174,292
+75,522
| +76% | +$1.88M | 0.04% | 248 |
|
|
2024
Q4 | $1.86M | Buy |
98,770
+70,220
| +246% | +$1.32M | 0.01% | 506 |
|
|
2024
Q3 | $430K | Sell |
28,550
-21,550
| -43% | -$324K | ﹤0.01% | 781 |
|
|
2024
Q2 | $1.43M | Sell |
50,100
-2,621
| -5% | -$75K | 0.02% | 471 |
|
|
2024
Q1 | $1.54M | Sell |
52,721
-10,640
| -17% | -$311K | 0.01% | 468 |
|
|
2023
Q4 | $2.14M | Buy |
63,361
+28,699
| +83% | +$968K | 0.01% | 445 |
|
|
2023
Q3 | $1.06M | Buy |
34,662
+20,351
| +142% | +$624K | 0.01% | 511 |
|
|
2023
Q2 | $573K | Sell |
14,311
-13,815
| -49% | -$554K | 0.01% | 754 |
|
|
2023
Q1 | $1.15M | Buy |
28,126
+451
| +2% | +$18.4K | 0.01% | 521 |
|
|
2022
Q4 | $1.07M | Buy |
+27,675
| New | +$1.07M | 0.01% | 496 |
|